9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To assess the safety of adalimumab in global clinical trials and postmarketing surveillance among patients with rheumatoid arthritis (RA).

          Related collections

          Author and article information

          Journal
          Ann. Rheum. Dis.
          Annals of the rheumatic diseases
          BMJ
          0003-4967
          0003-4967
          Jul 2006
          : 65
          : 7
          Affiliations
          [1 ] Clinical Research, Denver Arthritis Clinic, 200 Spruce Street, Suite 100, Denver, CO 80230, USA, and Department of Rheumatology, Charité Humboldt University, Berlin, Germany. crendon@denverarthritisclinic.com
          Article
          ard.2005.043166
          10.1136/ard.2005.043166
          1798196
          16439435
          6287934a-a068-41c4-90e4-4cf39b1f096b
          History

          Comments

          Comment on this article